Cetuximab monotherapy is active in patients with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN). Results of phase II study

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571135650196502656
  • NII Article ID
    10017234608
  • Data Source
    • CiNii Articles

Report a problem

Back to top